MedPath

Performance of a Hearing Aid Platform Including Different Styles of Hearing Aids

Not Applicable
Completed
Conditions
Hearing Loss, Bilateral or Unilateral
Interventions
Device: Hearing aid.
Registration Number
NCT02298452
Lead Sponsor
Phonak AG, Switzerland
Brief Summary

The reason for this study is to evaluate a new hearing aid product generation replacing the one on the market. The goal is to evaluate the audiological performance, usability as well as features and functions.

Detailed Description

This is a controlled, single blinded comparative study which is conducted monocentric at Phonak Headquarters in Staefa. The focus is to compare a new hearing aid product generation with the one on the market as well as with competitor devices regarding the audiological performance, usability as well as features and functions with the aid of 382 mild to profound hearing impaired subjects (18-90 yrs). The subjects, all of them native (Swiss) German speakers, individually conduct a number of laboratory standard tests and home trials (questionnaires) during nine weeks including weekly appointments of 2 hours.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
253
Inclusion Criteria
  • all kinds of hearing loss (sensorineural, conductive, combined)
  • all kinds of hearing loss (flat, sloping) which are in the fitting range of the hearing aids
  • mother tongue (swiss) german
Exclusion Criteria

Subjects

  • with a reduced mobility unable to attend weekly study appointments
  • without access to a number of different hearing situations
  • with strongly reduced ability to describe auditory impressions and the usage of the hearing aids
  • which are uncooperative so that it is not possible to record a valid pure tone audiogram
  • with a strongly reduced dexterity
  • with psychological problems
  • central hearing disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Hearing aidHearing aid.172 subjects with a mild hearing loss. 140 subjects with a moderate hearing loss. 70 subjects with a severe/ profound hearing loss.
Primary Outcome Measures
NameTimeMethod
Difference of speech intelligibility between devices based on Quest platform and Venture platform for different hearing aid styles3 years

For the objective measurements in laboratory situation, both a standard German speech sentence test in noise (SRT in dB) and a standard German monosyllable word test in quiet (speech discrimination in percent) are used to compare the speech intelligibility for both platforms. The results of the Venture platform of both tests should be at least the same or better than with the Quest platform.

Secondary Outcome Measures
NameTimeMethod
Subjective ratings of speech intelligibility during home trials3 years

For the subjective rating of speech intelligibility, questionnaires are used to compare the current platform Quest with the new platform Venture. The subjective impressions are rated by rating scales (e.g. Speech intelligibility in quiet: everything - most - half - little - nothing).

Subjective ratings of usability during home trials3 years

For the subjective rating of usability, questionnaires are used to compare the current platform Quest with the new platform Venture . The subjective impressions are rated by rating scales (e.g. Rating of the opening and closing of the battery door: very easy - easy - neither - difficult - very difficult).

Subjective ratings of sound quality during home trials3 years

For the subjective rating of sound quality, questionnaires are used to compare the current platform Quest with the new platform Venture. The subjective impressions are rated by rating scales (e.g. Sound quality for speech in quiet: good - dull - sharp - thin - echo - scratchy - unclear - noisy).

Trial Locations

Locations (1)

Phonak AG

🇨🇭

Stäfa, Zürich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath